                </a></li></ul></div><p><strong>Figure 4.  <span>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (âˆ’) expression of <em>Cyr61</em> (A), <em>CTGF</em> (B), and <em>WISP-1</em> (C).</span></strong></p><span>THISISTHEEND
